Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.


Clinical Trial Description

Goldenhar syndrome belongs to the heterogeneous spectrum of oculoauriculovertebral dysplasia. Several chromosomal abnormalities have been described associated with this spectrum, and furthermore mutations in different genes of development cause abnormalities of the jaw or facial asymmetries in human or mouse. To date, no gene has been identified as formally involved in the genesis of the OAVS, despite evidence of familial cases, mostly with autosomal dominant inheritance.

The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04056858
Study type Observational
Source University Hospital, Bordeaux
Contact
Status Completed
Phase
Start date September 29, 2012
Completion date January 8, 2014

See also
  Status Clinical Trial Phase
Completed NCT02224677 - Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
Completed NCT04351893 - Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology